Literature DB >> 657712

Kinetics of mezlocillin and carbenicillin.

S J Pancoast, H C Neu.   

Abstract

The kinetics of mezlocillin, a semisynthetic acylureido penicillin, more active than carbenicillin against many gram-negative bacteria, were compared with those of carbenicillin. Following an intravenous infusion of 4 gm in 5 min to 8 normal men there was an average serum level of 294 microgram/ml for mezlocillin and 365 microgram/ml for carbenicillin. The t1/2 for mezlocillin was 47 min and that for carbencillin was 70 min. The apparent volume of distribution was 13.4 L for mezlocillin and 14.4 L for carbenicillin. The mean urinary recovery of mezlocillin was 72% and that for carbenicillin was 92%. Constant infusion of 5 mg of mezlocillin over 2 hr gave steady-state levels of 234 microgram/ml. Half-life, apparent volume of distribution, and serum and renal clearance of mezlocillin after constant infusion were in the same range as those after rapid infusion.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 657712     DOI: 10.1002/cpt1978241108

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  16 in total

1.  Agar disk diffusion susceptibility characteristics of azlocillin, carbenicillin, mezlocillin, piperacillin, and ticarcillin.

Authors:  D Phaneuf; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-11       Impact factor: 5.191

2.  The kinetic disposition and dosage regimen for carbenicillin in buffalo calves.

Authors:  M S Bal; K S Brar
Journal:  Vet Res Commun       Date:  1989       Impact factor: 2.459

3.  Pharmacokinetics of intravenous piperacillin in patients undergoing chronic hemodialysis.

Authors:  E L Francke; G B Appel; H C Neu
Journal:  Antimicrob Agents Chemother       Date:  1979-12       Impact factor: 5.191

4.  [Antibiotic concentrations in the abdominal cavity as basis for antibacterial therapy of peritonitis: penetration of mezlocillin into the peritoneal exudate].

Authors:  D H Wittmann; J Welter; H H Schassan
Journal:  Infection       Date:  1982       Impact factor: 3.553

5.  Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.

Authors:  D Kampf; R Schurig; K Weihermüller; D Förster
Journal:  Antimicrob Agents Chemother       Date:  1980-07       Impact factor: 5.191

6.  Concentrations of mezlocillin in the serum, heart valves, muscle and subcutaneous tissue of patients undergoing open-heart surgery.

Authors:  F Daschner; H M Just; I Kappstein; H Spillner; V Schlosser
Journal:  Infection       Date:  1985 Jul-Aug       Impact factor: 3.553

7.  Determination of the ureidopenicillins azlocillin, mezlocillin and bay K 4999 in plasma by high performance liquid chromatography.

Authors:  U Gundert-Remy; J X De Vries
Journal:  Br J Clin Pharmacol       Date:  1979-12       Impact factor: 4.335

8.  The pharmacokinetics of furazlocillin in healthy humans.

Authors:  P H Hinderling; U Gundert-Remy; D Förster; W Gau
Journal:  J Pharmacokinet Biopharm       Date:  1983-02

9.  Comparative pharmacokinetics of two multiple-dose mezlocillin regimens in normal volunteers.

Authors:  P A Colaizzi; A A Coniglio; W J Poynor; N Vishniavsky; H T Karnes; R E Polk
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

10.  Mezlocillin pharmacokinetics after single intravenous doses to patients with varying degrees of renal function.

Authors:  N Frimodt-Möller; S Maigaard; R D Toothaker; R W Bundtzen; M V Brodey; W A Craig; P G Welling; P O Madsen
Journal:  Antimicrob Agents Chemother       Date:  1980-04       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.